{
    "code": "01025215",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01025215",
    "time": "2020-02-25 04:55:01",
    "許可證字號": "衛署藥製字第025215號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/03\/05",
    "註銷理由": "屆期未申請展延",
    "製造許可登錄編號": "",
    "有效日期": "97\/12\/31",
    "發證日期": "71\/04\/13",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102521508",
    "中文品名": "待益平錠１公絲（每斯克）",
    "英文品名": "DAIPINE TABLETS 1MG (N-METHYLSCOPOLAMINE METHYL SULFATE)",
    "適應症": "下列疾患時的痙攣性疼痛：（胃炎、胃潰瘍、十二指腸潰瘍）",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "METHSCOPOLAMINE METHYLSULFATE",
    "限制項目": "01國　產",
    "申請商名稱": "1111823200  臺灣陽生製藥工業股份有限公司",
    "申請商地址": "屏東巿龍華里龍華路３８１號",
    "主製造廠": [
        {
            "製造廠名稱": "1111823300  臺灣陽生製藥工業股份有限公司",
            "製造廠廠址": "屏東巿龍華里龍華路３８１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208003310",
            "成分名稱": "METHSCOPOLAMINE METHYLSULFATE",
            "含量描述": "1",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ]
}